These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15767652)

  • 1. Evaluation of extended-release diltiazem once daily for cats with hypertrophic cardiomyopathy.
    Wall M; Calvert CA; Sanderson SL; Leonhardt A; Barker C; Fallaw TK
    J Am Anim Hosp Assoc; 2005; 41(2):98-103. PubMed ID: 15767652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benazepril and subclinical feline hypertrophic cardiomyopathy: a prospective, blinded, controlled study.
    Taillefer M; Di Fruscia R
    Can Vet J; 2006 May; 47(5):437-45. PubMed ID: 16734369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for or against the efficacy of calcium channel blockers for management of hypertrophic cardiomyopathy in cats.
    Bright JM; Golden AL
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):1023-34. PubMed ID: 1683045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ivabradine on heart rate and left ventricular function in healthy cats and cats with hypertrophic cardiomyopathy.
    Riesen SC; Schober KE; Smith DN; Otoni CC; Li X; Bonagura JD
    Am J Vet Res; 2012 Feb; 73(2):202-12. PubMed ID: 22280379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical signs associated with severe ST segment elevation in three cats with a hypertrophic cardiomyopathy phenotype.
    Seo J; Kurosawa TA; Borgeat K; Novo Matos J; Hutchinson JC; Arthurs OJ; Luis Fuentes V
    J Vet Cardiol; 2024 Aug; 54():30-37. PubMed ID: 39004067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of treatment with atenolol on 5-year survival in cats with preclinical (asymptomatic) hypertrophic cardiomyopathy.
    Schober KE; Zientek J; Li X; Fuentes VL; Bonagura JD
    J Vet Cardiol; 2013 Jun; 15(2):93-104. PubMed ID: 23684504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum growth hormone concentration in feline hypertrophic cardiomyopathy.
    Kittleson MD; Pion PD; DeLellis LA; Mekhamer Y; Dybdal N; Lothrop CD
    J Vet Intern Med; 1992; 6(6):320-4. PubMed ID: 1484373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atenolol and survival in cats with asymptomatic hypertrophic cardiomyopathy.
    Vet Rec; 2016 Aug; 179(7):176. PubMed ID: 27516563
    [No Abstract]   [Full Text] [Related]  

  • 9. Atenolol in cats with subclinical hypertrophic cardiomyopathy: a double-blind, placebo-controlled, randomized clinical trial of effect on quality of life, activity, and cardiac biomarkers.
    Coleman AE; DeFrancesco TC; Griffiths EH; Lascelles BDX; Kleisch DJ; Atkins CE; Keene BW
    J Vet Cardiol; 2020 Aug; 30():77-91. PubMed ID: 32707333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the calcium channel-blocking agents diltiazem and verapamil for treatment of feline hypertrophic cardiomyopathy.
    Bright JM; Golden AL; Gompf RE; Walker MA; Toal RL
    J Vet Intern Med; 1991; 5(5):272-82. PubMed ID: 1836234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular and respiratory effects of incremental doses of dopamine and phenylephrine in the management of isoflurane-induced hypotension in cats with hypertrophic cardiomyopathy.
    Wiese AJ; Barter LS; Ilkiw JE; Kittleson MD; Pypendop BH
    Am J Vet Res; 2012 Jun; 73(6):908-16. PubMed ID: 22620707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac troponin I in three cat breeds with hypertrophic cardiomyopathy.
    Langhorn R; Willesen JL; Tarnow I; Kjelgaard-Hansen M; Koch J
    Vet Rec; 2016 May; 178(21):532. PubMed ID: 27076529
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful management of hypertrophic cardiomyopathy in a Matschie's tree kangaroo (Dendrolagus matschiei).
    Fredholm DV; Jones AE; Hall NH; Russell K; Heard DJ
    J Zoo Wildl Med; 2015 Mar; 46(1):95-9. PubMed ID: 25831580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrophic cardiomyopathy in a dog.
    Marks CA
    J Am Vet Med Assoc; 1993 Oct; 203(7):1020-2. PubMed ID: 8226248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of morphometric measurements and serum insulin-like growth factor concentration in healthy cats and cats with hypertrophic cardiomyopathy.
    Yang VK; Freeman LM; Rush JE
    Am J Vet Res; 2008 Aug; 69(8):1061-6. PubMed ID: 18672971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of myocardial function in obstructive hypertrophic cardiomyopathy cats with and without response to medical treatment by carvedilol.
    Suzuki R; Mochizuki Y; Yuchi Y; Yasumura Y; Saito T; Teshima T; Matsumoto H; Koyama H
    BMC Vet Res; 2019 Oct; 15(1):376. PubMed ID: 31660967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of enalapril in the treatment of feline hypertrophic cardiomyopathy.
    Rush JE; Freeman LM; Brown DJ; Smith FW
    J Am Anim Hosp Assoc; 1998; 34(1):38-41. PubMed ID: 9527429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of systemic hypertension in cats with amlodipine besylate.
    Henik RA; Snyder PS; Volk LM
    J Am Anim Hosp Assoc; 1997; 33(3):226-34. PubMed ID: 9138233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy.
    Hsu A; Kittleson MD; Paling A
    J Vet Cardiol; 2009 May; 11 Suppl 1():S63-70. PubMed ID: 19395334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End-stage hypertrophic cardiomyopathy in a cat.
    White AJ
    Can Vet J; 2015 May; 56(5):509-11. PubMed ID: 25969586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.